ZURICH, Oct. 29, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) (NASDAQ: NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and ...
Approval of the merger with Inmagene demonstrates strong shareholder support and confidence in the company's strategic direction. The reverse stock split aims to improve the market perception of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback